Centres d'excellences Laboratoires d'excellence

GENETIC & ENVIRONMENTAL CONTROL OF IMMUNE PHENOTYPE VARIANCE: ESTABLISHING A PATH TOWARDS PERSONALIZED MEDICINE

MILIEU INTERIEUR

Mots-clés : Health; immune system; genetic variability; heterogeneity; reference-based population; immune phenotypes; genotype-to-phenotype association; immune profiling; cell population; proteomics; transcriptomics; Host genetics; epigenetics; DNA methylation

Résumé

The Milieu Intérieur (MI) project was established in 2011 with the aim to define the parameters that characterise a healthy immune response and its natural variation across individuals and, in doing so, inform clinical strategies for managing disease. MI recruited a 1,000 healthy donor cohort, stratified by age and sex, from whom we built a biocollection consisting of genomic DNA, fecal samples, nasal swabs, stimulated whole blood supernatants and cell pellets, as well as fibroblast cell lines and iPSCs. These biological materials form the basis for a rich and growing data warehouse hosted at Institut Pasteur. Through the integrative analyses of multiple datasets, we quantified the extent of genetic control of cellular variability, transcriptional and humoral responses to infection, thymic function, as well as immune variability determined by the host microbiota. Ongoing work on the environmental and social factors that impact immunity is being carried out. Collaborations with CNRGH-CEA, Institut Roche, Genentech and Sanofi have also led to a unique, rich dataset of complete host and microbiome genomes, enabling to evaluate their impact on immune responses. MI recently completed a longitudinal 10-year follow-up study on the cohort. From this new study we are analysing how aging, genetics and environmental exposures affect immune variability and to assess health impacts occurring in this well-defined population. A recent partnership with Scienta Lab will apply novel artificial intelligence algorithms to provide new insights into the factors shaping immune variability. Through extensive collaborative partnerships, we have extended our approach to other healthy populations in Senegal and Hong Kong, as well as other age groups (neonatal, paediatric, and geriatric). The “MI concept” has been applied to 27 clinical studies, through which previously unknown immune perturbations have been identified in diverse conditions, ranging from infection to autoimmunity and cancer.

 

L'auteur de ce résumé est le coordinateur du projet, qui est responsable du contenu de ce résumé. L'ANR décline par conséquent toute responsabilité quant à son contenu.

Informations générales

Acronyme projet : MILIEU INTERIEUR
Référence projet : 10-LABX-0069
Région du projet : Île-de-France
Discipline : 5 - Bio Med
Aide PIA : 22 297 297 €
Début projet : avril 2011
Fin projet : décembre 2024

Coordination du projet : Luis QUINTANA-MURCI
Email : lluis.quintana-murci@pasteur.fr

Consortium du projet

Etablissement coordinateur : Institut Pasteur
Partenaire(s) : INSERM Délégation Paris IDF Centre-Nord (Paris 5), Institut Curie, INSERM Délégation Paris IDF Centre-Est, CNRS Ile-de-France Meudon, Université Sorbonne Paris Nord, Fondation IMAGINE, Université Paris Cité

Liens utiles

Explorez notre base de projets financés

 

 

L’ANR met à disposition ses jeux de données sur les projets, cliquez ici pour en savoir plus.

Inscrivez-vous à notre newsletter
pour recevoir nos actualités
S'inscrire à notre newsletter